Terms: = Lymphoma AND CEACAM5, CEA AND Treatment
53 results:
1. Diagnosis and treatment of hepatic cysts. Usefulness of intracystic tumor markers (cea and CA 19.9.).
Polette D; Mils K; López-Domínguez F; Barrios O; Leiva D; Puig I; Ramos E; Lladó L
Cir Esp (Engl Ed); 2024 Jan; 102(1):19-24. PubMed ID: 37980963
[TBL] [Abstract] [Full Text] [Related]
2. Circulating lung cancer biomarkers: From translational research to clinical practice.
Qian X; Meng QH
Tumour Biol; 2024; 46(s1):S27-S33. PubMed ID: 37927289
[TBL] [Abstract] [Full Text] [Related]
3. The Leser-Trélat Sign in a Patient with Gastric Adenocarcinoma.
Geber A; Hadžavdić A; Ljubojević Hadžavdić S
Acta Dermatovenerol Croat; 2023 Aug; 31(1):51-52. PubMed ID: 37843094
[TBL] [Abstract] [Full Text] [Related]
4. qRT-PCR analysis of ceacam5, KLK6, SLC35D3, MUC2 and POSTN in colon cancer lymph nodes-An improved method for assessment of tumor stage and prognosis.
Lindmark G; Olsson L; Sitohy B; Israelsson A; Blomqvist J; Kero S; Roshdy T; Söderholm M; Turi A; Isaksson J; Sakari T; Dooper M; Dafnis G; Forsberg P; Skovsted S; Walldén M; Kung CH; Rutegård M; Nordmyr J; Muhrbeck M; Hammarström S; Hammarström ML
Int J Cancer; 2024 Feb; 154(3):573-584. PubMed ID: 37700602
[TBL] [Abstract] [Full Text] [Related]
5. Different clinical characteristics and survival between surgically resected pure and combined small cell lung cancer.
Li Y; Wang Y; Zhou W; Chen Y; Lou Y; Qian F; Lu J; Jiang H; Xiang B; Zhang Y; Han B; Zhang W
Thorac Cancer; 2022 Oct; 13(19):2711-2722. PubMed ID: 36054506
[TBL] [Abstract] [Full Text] [Related]
6. JAK and mTOR inhibitors prevent cytokine release while retaining T cell bispecific antibody in vivo efficacy.
Leclercq G; Haegel H; Toso A; Zimmermann T; Green L; Steinhoff N; Sam J; Pulko V; Schneider A; Giusti AM; Challier J; Freimoser-Grundschober A; Larivière L; Odermatt A; Stern M; Umana P; Bacac M; Klein C
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35064010
[TBL] [Abstract] [Full Text] [Related]
7. ALK-positive lung cancer in a patient with recurrent brain metastases and meningeal dissemination who achieved long-term survival of more than seven years with sequential treatment of five ALK-inhibitors: A case report.
Yamamoto K; Toyokawa G; Kozuma Y; Shoji F; Yamazaki K; Takeo S
Thorac Cancer; 2021 Jun; 12(11):1761-1764. PubMed ID: 33939293
[TBL] [Abstract] [Full Text] [Related]
8. Prophylactic Cranial Irradiation in Patients With High-Risk Metastatic Non-Small Cell Lung Cancer: Quality of Life and Neurocognitive Analysis of a Randomized Phase II Study.
Maldonado F; Gonzalez-Ling A; Oñate-Ocaña LF; Cabrera-Miranda LA; Zatarain-Barrón ZL; Turcott JG; Flores-Estrada D; Lozano-Ruiz F; Cacho-Díaz B; Arrieta O
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):81-92. PubMed ID: 33915217
[TBL] [Abstract] [Full Text] [Related]
9. Accuracy evaluation of the C. elegans cancer test (N-NOSE) using a new combined method.
Inaba S; Shimozono N; Yabuki H; Enomoto M; Morishita M; Hirotsu T; di Luccio E
Cancer Treat Res Commun; 2021; 27():100370. PubMed ID: 33901923
[TBL] [Abstract] [Full Text] [Related]
10. Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment.
Ohtaki Y; Shimizu K; Suzuki H; Suzuki K; Tsuboi M; Mitsudomi T; Takao M; Murakawa T; Ito H; Yoshimura K; Okada M; Chida M;
Lung Cancer; 2021 Mar; 153():108-116. PubMed ID: 33482408
[TBL] [Abstract] [Full Text] [Related]
11. Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma.
Chen HJ; Tu CY; Huang KY; Chien CR; Hsia TC
PLoS One; 2020; 15(12):e0240736. PubMed ID: 33306683
[TBL] [Abstract] [Full Text] [Related]
12. Serum cea and CYFRA Levels in ALK-rearranged NSCLC Patients: Correlation With Distant Metastasis.
Numata T; Endo T; Yanai H; Ota K; Yamamoto Y; Shimizu K; Yamada H; Hayashihara K; Okauchi S; Satoh H; Yamada Y; Tamura T; Saito K; Kikuchi N; Kurishima K; Ishikawa H; Watanabe H; Shiozawa T; Hizawa N; Funayama Y; Hayashi S; Nakamura H; Yamashita T
In Vivo; 2020; 34(4):2095-2100. PubMed ID: 32606188
[TBL] [Abstract] [Full Text] [Related]
13. Correlation between combining
Ruan M; Liu L; Wang L; Lei B; Sun X; Chang C; Shen Y; Xie W
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1183-1197. PubMed ID: 31897590
[TBL] [Abstract] [Full Text] [Related]
14. Chimeric antigen receptor T cells in solid tumors: a war against the tumor microenvironment.
Zhao Z; Xiao X; Saw PE; Wu W; Huang H; Chen J; Nie Y
Sci China Life Sci; 2020 Feb; 63(2):180-205. PubMed ID: 31883066
[TBL] [Abstract] [Full Text] [Related]
15. Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in
Dietz S; Christopoulos P; Gu L; Volckmar AL; Endris V; Yuan Z; Ogrodnik SJ; Zemojtel T; Heussel CP; Schneider MA; Meister M; Muley T; Reck M; Schlesner M; Thomas M; Stenzinger A; Sültmann H
Cold Spring Harb Mol Case Stud; 2019 Dec; 5(6):. PubMed ID: 31753813
[TBL] [Abstract] [Full Text] [Related]
16. Value of serum tumor markers for predicting EGFR mutations and positive ALK expression in 1089 Chinese non-small-cell lung cancer patients: A retrospective analysis.
Wang S; Ma P; Ma G; Lv Z; Wu F; Guo M; Li Y; Tan Q; Song S; Zhou E; Geng W; Duan Y; Li Y; Jin Y
Eur J Cancer; 2020 Jan; 124():1-14. PubMed ID: 31707279
[TBL] [Abstract] [Full Text] [Related]
17. Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30
Hombach AA; Rappl G; Abken H
Mol Ther; 2019 Oct; 27(10):1825-1835. PubMed ID: 31331813
[TBL] [Abstract] [Full Text] [Related]
18. Cost-effectiveness analysis of rasburicase over standard of care for the prevention and treatment of tumor lysis syndrome in children with hematologic malignancies in China.
Hu S; Han Y; Zhang W; Zhang T; Yao X; Liu L
J Med Econ; 2019 Aug; 22(8):742-750. PubMed ID: 30939962
[No Abstract] [Full Text] [Related]
19. Correlation between pre-treatment serum carcinoembryonic antigen levels and genotypes in a large population of Chinese people with advanced lung adenocarcinoma.
Liu J; Zhao YQ; Han X; Hu XF; Wu HB; Chen LJ; Song YP
Intern Med J; 2019 May; 49(5):634-643. PubMed ID: 30379408
[TBL] [Abstract] [Full Text] [Related]
20. [A Case of Colon Cancer with Brain, Liver and Lung Metastasis Successfully Treated with Bevacizumab plus Xelox Therapy].
Tokoro T; Nakamura K; Hirose A; Nakanuma S; Okamoto K; Kinoshita J; Makino I; Hayashi H; Oyama K; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fushida S; Ohta T
Gan To Kagaku Ryoho; 2018 Mar; 45(3):521-523. PubMed ID: 29650925
[TBL] [Abstract] [Full Text] [Related]
[Next]
